Forbes – 25.8 Million Diabetes Patients Need What Grove Instruments Is Developing

Clinical trials go well in 2013, its CEO expects to initiate the process of seeking Food and Drug Administration (FDA) approval for the device in 2014. And if that goes well, Worcester, Mass.-based Grove Instruments’ product could become available for use by the 25.8 million U.S. children and adults with diabetes by 2015 or 2016.

Read more

Posted in Glucose & Insulin